Notable Downgrades: Rosetta Resources (ROSE), American Airlines (AAL), St. Jude Medical (STJ), Vodafone Group (VOD), Salix Pharmaceuticals (SLXP)

Analysts at Wunderlich downgraded Rosetta Resources, Inc. (ROSE) from ‘Buy‘ to ‘Hold‘ in a research report issued to clients on Tuesday.

The target price for ROSE is lowered from $37 to $22.

On valuation measures, Rosetta Resources Inc. stock it is trading at a forward P/E multiple of 315.58x, and at a multiple of 7.36x this year’s estimated earnings.

The T-12-month revenue at Rosetta Resources Inc. is $1.01 billion. Rosetta ‘s ROE for the same period is 11.26%.

Shares of the $1.16 billion market cap company are down 51.84% year-over-year, down 1.97% year-to-date.

ROSE, currently with a median Wall Street price target of $28.00 and a high target of $53.00, dropped $3.01 to $18.86 in recent trading.

The chart below shows where the equity has traded over the past 52-weeks.

American Airlines Group Inc. (AAL) was downgraded from ‘Outperform‘ to ‘Market Perform‘ while the price target was raised from $55 to $66 at Cowen.

Shares have traded today between $49.36 and $50.48 with the price of the stock fluctuating between $28.10 to $56.20 over the last 52 weeks.

American Airlines Group Inc. shares are currently changing hands at 12.74x this year’s forecasted earnings, compared to the industry’s 36.07x earnings multiple. Ticker has a t-12 price/sales ratio of 0.85. EPS for the same period registers at $3.93.

Shares of AAL have lost $1.25 to $50.06 in mid-day trading on Tuesday, giving it a market cap of roughly $35.35 billion. The stock traded as high as $56.20 in January 26, 2015.

Credit Suisse (CS) reported on Tuesday that they have lowered their rating for St. Jude Medical Inc. (STJ). The firm has downgraded STJ from ‘Neutral‘ to ‘Underperform‘.

As for passive income investors, the company pays shareholders $1.08 per share annually in dividends.

St. Jude Medical Inc. recently traded at $67.23, a loss of $1.32 over Monday’s closing price. The name has a current market capitalization of $19.54 billion.

Vodafone Group Public Limited Company (VOD) had its rating lowered from ‘Neutral‘ to ‘Underperform‘ by analysts at Bank of America (BAC) on Tuesday.

VOD was down $1.21 at $34.77 in mid-day trade, moving within a 52-week range of $28.63 to $41.90. The name, valued at $92.02 billion, opened at $34.85.

On valuation measures, Vodafone Group PLC ADS shares are currently priced at 1.29x this year’s forecasted earnings. Ticker has a t-12 price/sales ratio of 1.55. EPS for the same period registers at $26.99.

As for passive income investors, the firm pays stockholders $1.09 per share annually in dividends, yielding 3.00%.

Salix Pharmaceuticals Ltd. (SLXP) was downgraded by Cantor Fitzgerald from a ‘Buy‘ rating to a ‘Hold‘ rating in a research report issued to clients on Tuesday. They currently have a $158 price objective on the stock’ up from their previous price target of $151.

SLXP closed at $155.76 on Monday and is currently trading up $0.94.

In the past 52 weeks, shares of the company have traded between a low of $86.00 and a high of $172.98 and are now trading at $156.70. Shares are up 47.82% year-over-year ; up 35.51% year-to-date.

Be the first to comment

Leave a Reply

Your email address will not be published.


*